We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVSB icon
2851
Riverview Bancorp
RVSB
$106M
$72K ﹤0.01%
11,352
+11,004
+3,162% +$75.5K
CDMO
2852
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$72K ﹤0.01%
3,778
-8,627
-70% -$157K
TCN
2853
DELISTED
Tricon Residential Inc.
TCN
$72K ﹤0.01%
8,148
+3,865
+90% +$40.8K
PCTI
2854
DELISTED
PCTEL, Inc. Common Stock
PCTI
$72K ﹤0.01%
15,253
+940
+7% +$4.47K
RETA
2855
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$72K ﹤0.01%
2,881
+1,840
+177% +$51K
BCBP icon
2856
BCB Bancorp
BCBP
$161M
$71K ﹤0.01%
4,236
+3,357
+382% +$61.7K
LYG icon
2857
Lloyds Banking Group
LYG
$90B
$71K ﹤0.01%
+39,801
New +$82.6K
MUFG icon
2858
Mitsubishi UFJ Financial
MUFG
$260B
$71K ﹤0.01%
15,739
-8,586
-35% -$44.7K
NGG icon
2859
National Grid
NGG
$81.6B
$71K ﹤0.01%
1,496
+690
+86% +$41.5K
PAHC icon
2860
Phibro Animal Health
PAHC
$1.37B
$71K ﹤0.01%
5,378
+4,364
+430% +$75.3K
SRS icon
2861
ProShares UltraShort Real Estate
SRS
$15.7M
$71K ﹤0.01%
+856
New +$55.1K
TCRT icon
2862
Alaunos Therapeutics
TCRT
$4.88M
$71K ﹤0.01%
277
+226
+443% +$65.6K
CPE
2863
DELISTED
Callon Petroleum Company
CPE
$71K ﹤0.01%
2,026
-495
-20% -$19.8K
CCF
2864
DELISTED
Chase Corporation
CCF
$71K ﹤0.01%
851
-302
-26% -$26.7K
DIN icon
2865
Dine Brands
DIN
$462M
$70K ﹤0.01%
1,094
+397
+57% +$27.7K
RACE icon
2866
Ferrari
RACE
$72.5B
$70K ﹤0.01%
380
+239
+170% +$47.7K
VTYX
2867
DELISTED
Ventyx Biosciences
VTYX
$70K ﹤0.01%
1,996
+183
+10% +$4.05K
LOGC
2868
DELISTED
ContextLogic
LOGC
$70K ﹤0.01%
3,188
-1,250
-28% -$51.8K
LGF.B
2869
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$70K ﹤0.01%
10,134
+6,479
+177% +$58.8K
ESMT
2870
DELISTED
EngageSmart, Inc.
ESMT
$70K ﹤0.01%
3,370
-398
-11% -$7.8K
BVH
2871
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$70K ﹤0.01%
4,258
+3,343
+365% +$75.2K
BASE
2872
DELISTED
Couchbase
BASE
$69K ﹤0.01%
4,831
+1,913
+66% +$30.9K
COLD icon
2873
Americold
COLD
$4.17B
$69K ﹤0.01%
2,812
-2,005
-42% -$60.6K
ENVA icon
2874
Enova International
ENVA
$6.48B
$69K ﹤0.01%
2,358
+1,173
+99% +$39.4K
LESL icon
2875
Leslie's
LESL
$7.21M
$69K ﹤0.01%
235
+125
+114% +$37.5K
113 114
115
116 117

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.